Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 2 (2005), Issue 3 (March)

1. Diabetes and the World Wide Web.
   Diabetes Technol Ther, 7(1): 225-9. [Abstract] [Full-text]
2. A national progress report on diabetes: successes and challenges.
   Diabetes Technol Ther, 7(1): 198-203. [Abstract] [Full-text]
3. Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study.
   Diabetes Technol Ther, 7(1): 109-14. [Abstract] [Full-text]
4. Pharmacokinetics of intravenous insulin delivery in humans with type 1 diabetes.
   Diabetes Technol Ther, 7(1): 83-93. [Abstract] [Full-text]
5. Grading system to assess clinical performance of closed-loop glucose control.
   Diabetes Technol Ther, 7(1): 72-82. [Abstract] [Full-text]
6. The Intelligent Dosing System: application for insulin therapy and diabetes management.
   Diabetes Technol Ther, 7(1): 58-71. [Abstract] [Full-text]
7. Run-to-run control of meal-related insulin dosing.
   Diabetes Technol Ther, 7(1): 48-57. [Abstract] [Full-text]
8. Community diabetes: an East London perspective.
   J R Soc Med, 98(3): 96-100. [Abstract] [Full-text]
9. Anemia with impaired erythropoietin response in diabetic patients.
   Arch Intern Med, 165(4): 466-9. [Abstract] [Full-text]
10. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea.
    Arch Intern Med, 165(4): 447-52. [Abstract] [Full-text]
11. Pulse oximetry as a potential screening tool for lower extremity arterial disease in asymptomatic patients with diabetes mellitus.
    Arch Intern Med, 165(4): 442-6. [Abstract] [Full-text]
12. Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000.
    Arch Intern Med, 165(4): 436-41. [Abstract] [Full-text]
13. Sex differences in the effect of diabetes duration on coronary heart disease mortality.
    Arch Intern Med, 165(4): 430-5. [Abstract] [Full-text]
14. Transaminitis after pancreatic islet transplantation.
    J Am Coll Surg, 200(3): 353-61. [Abstract] [Full-text]
15. Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats.
    Biochem Biophys Res Commun, 329(2): 726-32. [Abstract] [Full-text]
16. Reliability of free-flap coverage in diabetic foot ulcers.
    Microsurgery, 25(2): 107-12. [Abstract] [Full-text]
17. Non-invasive cardiovascular risk assessment in women with type 2 diabetes.
    J Vasc Nurs, 23(1): 2-7; quiz 8-9. [Abstract] [Full-text]
18. Home use of the GlucoWatch G2 biographer in children with diabetes.
    Pediatrics, 115(3): 662-6. [Abstract] [Full-text]
19. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus.
    Pediatrics, 115(3): e290-6. [Abstract] [Full-text]
20. In vivo glucose monitoring: the clinical reality and the promise.
    Biosens Bioelectron, 20(10): 1897-902. [Abstract] [Full-text]
21. The effects of acarbose and Rumex patientia L. on ultrastructural and biochemical changes of pancreatic B cells in streptozotocin-induced diabetic rats.
    J Ethnopharmacol, 97(3): 555-9. [Abstract] [Full-text]
22. Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats.
    J Ethnopharmacol, 97(3): 497-501. [Abstract] [Full-text]
23. Effects of Syzygium cordatum (Hochst.) [Myrtaceae] leaf extract on plasma glucose and hepatic glycogen in streptozotocin-induced diabetic rats.
    J Ethnopharmacol, 97(3): 485-90. [Abstract] [Full-text]
24. Acute and chronic hypoglycemic effect of Ibervillea sonorae root extracts-II.
    J Ethnopharmacol, 97(3): 447-52. [Abstract] [Full-text]
25. Swedish and Middle-Eastern-born women's beliefs about gestational diabetes.
    Midwifery, 21(1): 44-60. [Abstract] [Full-text]
26. Inhibition of choroidal angiogenesis by calcium dobesilate in normal Wistar and diabetic GK rats.
    Eur J Pharmacol, 510(1): 149-56. [Abstract] [Full-text]
27. A new tactic to treat postprandial hyperlipidemia in diabetic rats with gastroparesis by improving gastrointestinal transit.
    Eur J Pharmacol, 510(1): 113-20. [Abstract] [Full-text]
28. Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes.
    Clin Transplant, 19(2): 279-85. [Abstract] [Full-text]
29. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    Aliment Pharmacol Ther, 21(5): 519-24. [Abstract] [Full-text]
30. Food consumption and the incidence of type II diabetes mellitus.
    Eur J Clin Nutr, 59(3): 441-8. [Abstract] [Full-text]
31. Effects of single and long-term administration of wheat albumin on blood glucose control: randomized controlled clinical trials.
    Eur J Clin Nutr, 59(3): 384-92. [Abstract] [Full-text]
32. Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein.
    Eur J Clin Nutr, 59(3): 411-8. [Abstract] [Full-text]
33. Risperidone-associated transient diabetic ketoacidosis and diabetes mellitus type 1 in a patient treated with valproate and lithium.
    Pharmacopsychiatry, 38(2): 105-6. [Abstract] [Full-text]
34. Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue.
    Mol Cell Biol, 25(6): 2498-510. [Abstract] [Full-text]
35. Effect of dietary docosahexaenoic acid on the endothelium-dependent vasorelaxation in diabetic rats.
    Clin Exp Pharmacol Physiol, 32(3): 184-90. [Abstract] [Full-text]
36. Relationship between cerebroplacental Doppler ratio and birth weight in postdates pregnancies.
    Ultrasound Obstet Gynecol, 25(3): 265-9. [Abstract] [Full-text]
37. Interleukin 18 promoter polymorphisms are not strongly associated with type I diabetes in a UK population.
    Genes Immun, 6(2): 171-4. [Abstract] [Full-text]
38. The effect of PDE5 inhibition on the erectile function in streptozotocin-induced diabetic rats.
    Int J Impot Res, 17(2): 134-41. [Abstract] [Full-text]
39. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review.
    J Am Diet Assoc, 105(3): 428-40. [Abstract] [Full-text]
40. Risk factors for cognitive dysfunction after coronary artery bypass graft surgery in patients with type 2 diabetes.
    J Thorac Cardiovasc Surg, 129(3): 576-83. [Abstract] [Full-text]
41. Impaired KATP channel function in the fetoplacental circulation of patients with type 1 diabetes mellitus.
    Am J Obstet Gynecol, 192(3): 973-9. [Abstract] [Full-text]
42. Aberrant patterns of cellular communication in diabetes-induced embryopathy in rats: II, apoptotic pathways.
    Am J Obstet Gynecol, 192(3): 967-72. [Abstract] [Full-text]
43. Seasonal patterns in monthly hemoglobin A1c values.
    Am J Epidemiol, 161(6): 565-74. [Abstract] [Full-text]
44. Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women.
    Am J Epidemiol, 161(6): 557-64. [Abstract] [Full-text]
45. Magnetic resonance imaging and diffusion-weighted imaging changes after hypoglycemic coma.
    J Neuroimaging, 15(2): 193-6. [Abstract] [Full-text]
46. Depression in diabetic patients: the relationship between mood and glycemic control.
    J Diabetes Complications, 19(2): 113-22. [Abstract] [Full-text]
47. Diabetic lower extremity infection: influence of physical, psychological, and social factors.
    J Diabetes Complications, 19(2): 107-12. [Abstract] [Full-text]
48. Diabetes-related comorbidities in Asian Americans: results of a national health survey.
    J Diabetes Complications, 19(2): 101-6. [Abstract] [Full-text]
49. Subjective well-being before and after the onset of diabetes mellitus: results of the Nord-Trøndelag Health Study.
    J Diabetes Complications, 19(2): 88-95. [Abstract] [Full-text]
50. Hyperglycemia and its effect after acute myocardial infarction on cardiovascular outcomes in patients with Type 2 diabetes mellitus (HEART2D) Study design.
    J Diabetes Complications, 19(2): 80-7. [Abstract] [Full-text]
51. The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial.
    J Diabetes Complications, 19(2): 74-9. [Abstract] [Full-text]
52. Aldose reductase (AC)n gene polymorphism and susceptibility to diabetic retinopathy in Type 2 diabetes in Caucasians.
    J Diabetes Complications, 19(2): 70-3. [Abstract] [Full-text]
53. A novel polymorphism in the 5' flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with Type 1 diabetes mellitus.
    J Diabetes Complications, 19(2): 65-9. [Abstract] [Full-text]
54. Short-term tolerance of pulse methylprednisolone therapy in patients with diabetes mellitus.
    Ophthalmology, 112(3): 511-5. [Abstract] [Full-text]
55. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes.
    Am J Med, 118(3): 276-84. [Abstract] [Full-text]
56. The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin.
    Am J Med, 118(3): 205-11. [Abstract] [Full-text]
57. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis.
    Nat Med, 11(3): 320-7. [Abstract] [Full-text]
58. Glucose transporters in diabetic nephropathy.
    Pediatr Nephrol, 20(4): 447-51. [Abstract] [Full-text]
59. Population genetics of CAPN10 and GPR35: implications for the evolution of type 2 diabetes variants.
    Am J Hum Genet, 76(4): 548-60. [Abstract] [Full-text]
60. Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo.
    Circ Res, 96(4): 435-41. [Abstract] [Full-text]
61. Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst.
    FASEB J, 19(3): 401-3. [Abstract] [Full-text]
62. Improvement of metabolic state in an animal model of nutrition-dependent type 2 diabetes following treatment with S 23521, a new glucagon-like peptide 1 (GLP-1) analogue.
    J Endocrinol, 184(3): 505-13. [Abstract] [Full-text]
63. Urinary endogenous concentrations of GHB and its isomers in healthy humans and diabetics.
    Forensic Sci Int, 149(2): 171-9. [Abstract] [Full-text]
64. A case of rosiglitazone exposure in the second trimester of pregnancy.
    Reprod Toxicol, 19(4): 563-4. [Abstract] [Full-text]
65. Design of a portable urine glucose monitoring system for health care.
    Comput Biol Med, 35(4): 275-86. [Abstract] [Full-text]
66. Diabetes increases expression of ICAM after a brief period of cerebral ischemia.
    J Neuroimmunol, 161(1): 61-7. [Abstract] [Full-text]
67. Diabetes on the college campus.
    Pediatr Clin North Am, 52(1): 279-305, xi. [Abstract] [Full-text]
68. Quantifying macrophage defects in type 1 diabetes.
    J Theor Biol, 233(4): 533-51. [Abstract] [Full-text]
69. Neuronal and astroglial alterations in the hippocampus of a mouse model for type 1 diabetes.
    Brain Res, 1038(1): 22-31. [Abstract] [Full-text]
70. Long-chain omega6 polyunsaturated fatty acids in erythrocyte phospholipids are associated with insulin resistance in non-obese type 2 diabetics.
    Clin Chim Acta, 354(1): 195-9. [Abstract] [Full-text]
71. Impairment of sodium pump and Na/H exchanger in erythrocytes from non-insulin dependent diabetes mellitus patients: effect of tea catechins.
    Clin Chim Acta, 354(1): 59-67. [Abstract] [Full-text]
72. A sensitive assay of red blood cell sorbitol level by high performance liquid chromatography: potential for diagnostic evaluation of diabetes.
    Clin Chim Acta, 354(1): 41-7. [Abstract] [Full-text]
73. Autoantibodies in Type 1 diabetes.
    Clin Chim Acta, 354(1): 35-40. [Abstract] [Full-text]
74. Phenotypes of the N88S Berardinelli-Seip congenital lipodystrophy 2 mutation.
    Ann Neurol, 57(3): 415-24. [Abstract] [Full-text]
75. Macrocephaly-cutis marmorata telangiectatica congenita syndrome--prenatal signs in ultrasonography.
    Prenat Diagn, 25(2): 129-32. [Abstract] [Full-text]
76. Genetic variants in the calpain-10 gene and the development of type 2 diabetes in the Japanese population.
    J Hum Genet, 50(2): 92-8. [Abstract] [Full-text]
77. Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study.
    Diabetologia, 48(2): 370-8. [Abstract] [Full-text]
78. mt-Nd2 Allele of the ALR/Lt mouse confers resistance against both chemically induced and autoimmune diabetes.
    Diabetologia, 48(2): 261-7. [Abstract] [Full-text]
79. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus.
    Diabetologia, 48(2): 294-300. [Abstract] [Full-text]
80. The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes.
    Diabetologia, 48(2): 309-16. [Abstract] [Full-text]
81. Glutamate uptake in retinal glial cells during diabetes.
    Diabetologia, 48(2): 351-60. [Abstract] [Full-text]
82. Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes.
    Diabetologia, 48(2): 379-85. [Abstract] [Full-text]
83. Use of a reference four-component model to define the effects of insulin treatment on body composition in type 2 diabetes: the 'Darwin study'.
    Diabetologia, 48(2): 222-9. [Abstract] [Full-text]
84. Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis.
    J Hum Genet, 50(2): 84-91. [Abstract] [Full-text]
85. Genetic testing for maturity onset diabetes of the young: uptake, attitudes and comparison with hereditary non-polyposis colorectal cancer.
    Diabetologia, 48(2): 242-50. [Abstract] [Full-text]
86. Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c.
    Diabetologia, 48(2): 345-50. [Abstract] [Full-text]
87. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes.
    Diabetologia, 48(2): 290-3. [Abstract] [Full-text]
88. Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients.
    Diabetologia, 48(2): 282-9. [Abstract] [Full-text]
89. Symptoms, signs and complications in newly diagnosed type 2 diabetic patients, and their relationship to glycaemia, blood pressure and weight.
    Diabetologia, 48(2): 210-4. [Abstract] [Full-text]
90. Orosomucoid in urine is a powerful predictor of cardiovascular mortality in normoalbuminuric patients with type 2 diabetes at five years of follow-up.
    Diabetologia, 48(2): 386-93. [Abstract] [Full-text]
91. Determinants of subclinical diabetic heart disease.
    Diabetologia, 48(2): 394-402. [Abstract] [Full-text]
92. Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population.
    Diabetologia, 48(2): 235-41. [Abstract] [Full-text]
93. Short-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats.
    Exp Physiol, 90(2): 237-45. [Abstract] [Full-text]
94. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.
    Am J Kidney Dis, 45(3): 494-501. [Abstract] [Full-text]
95. Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
    Am J Kidney Dis, 45(3): 485-93. [Abstract] [Full-text]
96. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study.
    Gut, 54(4): 533-9. [Abstract] [Full-text]
97. Evolution of serum alpha-tocopherol in the postprandial and postabsorptive phases in type 1 diabetes mellitus.
    Ann N Y Acad Sci, 1031: 439-42. [Abstract] [Full-text]
98. Oxidative stress and antioxidant treatment in diabetes.
    Ann N Y Acad Sci, 1031: 204-13. [Abstract] [Full-text]
99. The effect of rosiglitazone on urine albumin excretion in patients with type 2 diabetes mellitus and hypertension.
    Am J Hypertens, 18(2): 227-34. [Abstract] [Full-text]
100. Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes.
     Am J Hypertens, 18(2): 220-6. [Abstract] [Full-text]
101. Prevention of cardiovascular outcomes in type 2 diabetes mellitus: trials on the horizon.
     Endocrinol Metab Clin North Am, 34(1): 221-35. [Abstract] [Full-text]
102. The prevention of type 2 diabetes mellitus.
     Endocrinol Metab Clin North Am, 34(1): 199-219, viii. [Abstract] [Full-text]
103. Novel pharmacologic agents for type 2 diabetes.
     Endocrinol Metab Clin North Am, 34(1): 155-97. [Abstract] [Full-text]
104. Insulin therapy in people who have dysglycemia and type 2 diabetes mellitus: can it offer both cardiovascular protection and beta-cell preservation?
     Endocrinol Metab Clin North Am, 34(1): 137-54. [Abstract] [Full-text]
105. Potential cardiovascular benefits of insulin sensitizers.
     Endocrinol Metab Clin North Am, 34(1): 117-35. [Abstract] [Full-text]
106. Hospital management of diabetes.
     Endocrinol Metab Clin North Am, 34(1): 99-116. [Abstract] [Full-text]
107. Glycemic management of type 2 diabetes: an emerging strategy with oral agents, insulins, and combinations.
     Endocrinol Metab Clin North Am, 34(1): 77-98. [Abstract] [Full-text]
108. Hypertension management in type 2 diabetes mellitus: recommendations of the Joint National Committee VII.
     Endocrinol Metab Clin North Am, 34(1): 63-75. [Abstract] [Full-text]
109. The dyslipidemia of diabetes mellitus: giving triglycerides and high-density lipoprotein cholesterol a higher priority?
     Endocrinol Metab Clin North Am, 34(1): 27-48. [Abstract] [Full-text]
110. Management of diabetic dyslipidemia.
     Endocrinol Metab Clin North Am, 34(1): 1-25, v. [Abstract] [Full-text]
111. Distribution of atrial natriuretic peptide and its effects on contraction and intracellular calcium in ventricular myocytes from streptozotocin-induced diabetic rat.
     Peptides, 26(4): 691-700. [Abstract] [Full-text]
112. Cardiovascular effects of endomorphins in alloxan-induced diabetic rats.
     Peptides, 26(4): 607-14. [Abstract] [Full-text]
113. Intravenous infusion for the treatment of diabetic and ischaemic non-healing pedal ulcers.
     J Eur Acad Dermatol Venereol, 19(2): 158-62. [Abstract] [Full-text]
114. Role of lipid control in diabetic nephropathy.
     Kidney Int Suppl. [Abstract] [Full-text]
115. Diabetic nephropathy: recent insights into the pathophysiology and the progression of diabetic nephropathy.
     Kidney Int Suppl. [Abstract] [Full-text]
116. Genetics of common progressive renal disease.
     Kidney Int Suppl. [Abstract] [Full-text]
117. Insulin protects against amyloid beta-peptide toxicity in brain mitochondria of diabetic rats.
     Neurobiol Dis, 18(3): 628-37. [Abstract] [Full-text]
118. A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetes.
     Exp Neurol, 192(2): 407-19. [Abstract] [Full-text]
119. Coffee consumption and human health--beneficial or detrimental?--Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus.
     Mol Nutr Food Res, 49(3): 274-84. [Abstract] [Full-text]
120. Reamputation, mortality, and health care costs among persons with dysvascular lower-limb amputations.
     Arch Phys Med Rehabil, 86(3): 480-6. [Abstract] [Full-text]
121. Diabetes and premature menopause: is their co-existence detrimental to the skeleton?
     Eur J Endocrinol, 152(3): 437-42. [Abstract] [Full-text]
122. The natural history of post-traumatic neurohypophysial dysfunction.
     Eur J Endocrinol, 152(3): 371-7. [Abstract] [Full-text]
123. Left ventricular function in patients with type 2 diabetes mellitus.
     Am J Cardiol, 95(6): 798-801. [Abstract] [Full-text]
124. The role of tyrosine kinase-mediated pathways in diabetes-induced alterations in responsiveness of rat carotid artery.
     Auton Autacoid Pharmacol, 25(2): 69-78. [Abstract] [Full-text]
125. The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes.
     J Clin Endocrinol Metab, 90(3): 1495-501. [Abstract] [Full-text]
126. Exercise is required for visceral fat loss in postmenopausal women with type 2 diabetes.
     J Clin Endocrinol Metab, 90(3): 1511-8. [Abstract] [Full-text]
127. Health insurance for type 1 diabetes mellitus: US competition and French coverage.
     Nurs Outlook, 53(1): 26-32. [Abstract] [Full-text]
128. Identity and adherence in a diabetes patient: transformations in psychotherapy.
     Qual Health Res, 15(3): 312-24. [Abstract] [Full-text]
129. Primary prevention of diabetes: what can be done and how much can be prevented?
     Annu Rev Public Health, 26: 445-67. [Abstract] [Full-text]
130. Prevalence of diabetes mellitus in patients receiving depot neuroleptics or clozapine.
     Arch Psychiatr Nurs, 19(1): 30-4. [Abstract] [Full-text]
131. Gestational diabetes mellitus.
     J Clin Invest, 115(3): 485-91. [Abstract] [Full-text]
132. Identification of angiotensin converting enzyme 2 in the rodent retina.
     Curr Eye Res, 29(6): 419-27. [Abstract] [Full-text]
133. Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.
     Autoimmunity, 37(8): 555-67. [Abstract] [Full-text]
134. The association between health insurance coverage and diabetes care; data from the 2000 Behavioral Risk Factor Surveillance System.
     Health Serv Res, 40(2): 361-72. [Abstract] [Full-text]
135. Keller procedure for the treatment of resistant plantar ulceration of the hallux.
     J Foot Ankle Surg, 44(2): 133-6. [Abstract] [Full-text]
136. Perceived barriers to diabetic eye care: qualitative study of patients and physicians.
     Arch Ophthalmol, 123(3): 387-91. [Abstract] [Full-text]
137. Prior hospitalization for epilepsy, diabetes, and stroke and subsequent glioma and meningioma risk.
     Cancer Epidemiol Biomarkers Prev, 14(3): 643-50. [Abstract] [Full-text]
138. Providing diabetes education and care to underserved patients in a collaborative practice at a utah community health center.
     Pharmacotherapy, 25(1): 96-109. [Abstract] [Full-text]
139. Clinical examination accurately locates capillary nonperfusion in diabetic retinopathy.
     Am J Ophthalmol, 139(3): 555-7. [Abstract] [Full-text]
140. Dry eye in diabetic patients.
     Am J Ophthalmol, 139(3): 498-503. [Abstract] [Full-text]
141. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
     Am J Ophthalmol, 139(3): 476-81. [Abstract] [Full-text]
142. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema.
     Am J Ophthalmol, 139(3): 447-54. [Abstract] [Full-text]
143. Humoral methylglyoxal level reflects glycemic fluctuation.
     Clin Biochem, 38(4): 379-83. [Abstract] [Full-text]
144. Association of plasma cholesteryl ester transfer protein activity and polymorphism with coronary artery disease extent in Tunisian type II diabetic patients.
     Clin Biochem, 38(4): 373-8. [Abstract] [Full-text]
145. Rapid monitoring of diabetes-induced lipid peroxidation by Fourier transform infrared spectroscopy: evidence from rat liver microsomal membranes.
     Anal Biochem, 339(1): 36-40. [Abstract] [Full-text]
146. Experimental gingivitis in type 1 diabetics: a controlled clinical and microbiological study.
     J Clin Periodontol, 32(3): 310-6. [Abstract] [Full-text]
147. The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus.
     J Clin Periodontol, 32(3): 266-72. [Abstract] [Full-text]
148. Metabolic memory in diabetes--focus on insulin.
     Diabetes Metab Res Rev, 21(2): 85-90. [Abstract] [Full-text]
149. Pancreatic agenesis as cause for neonatal diabetes mellitus.
     Klin Padiatr, 217(2): 76-81. [Abstract] [Full-text]
150. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
     Cardiovasc Res, 66(1): 150-61. [Abstract] [Full-text]
151. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice.
     Endocrinology, 146(4): 1956-64. [Abstract] [Full-text]
152. Healing times and prediction of wound healing in neuropathic diabetic foot ulcers: a prospective study.
     Exp Clin Endocrinol Diabetes, 113(2): 90-3. [Abstract] [Full-text]
153. Coincidence of high antiislet and antithyroid autoantibody titles in first-degree relatives of patients with type 1 diabetes.
     Exp Clin Endocrinol Diabetes, 113(2): 85-9. [Abstract] [Full-text]
154. The effect of short-term glycemic regulation with gliclazide and metformin on postprandial lipemia.
     Exp Clin Endocrinol Diabetes, 113(2): 80-4. [Abstract] [Full-text]
155. Going high with type 1 diabetes.
     High Alt Med Biol, 6(1): 14-21. [Abstract] [Full-text]
156. Current strategies in diagnostics and endocrine treatment of patients with childhood craniopharyngioma during follow-up--recommendations in KRANIOPHARYNGEOM 2000.
     Onkologie, 28(3): 150-6. [Abstract] [Full-text]
157. Coronary heart disease prevention in clinical practice: are patients with diabetes special? Evidence from two studies of older men and women.
     Heart, 91(4): 451-5. [Abstract] [Full-text]
158. Secondary hypothyroidism following head trauma in a cat.
     J Feline Med Surg, 7(2): 135-9. [Abstract] [Full-text]
159. Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation.
     Aliment Pharmacol Ther, 21(6): 623-32. [Abstract] [Full-text]
160. Morphoquantitative aspects of nitrergic myoenteric neurons from the stomach of diabetic rats supplemented with acetyl-L-carnitine.
     Anat Histol Embryol, 34(2): 93-7. [Abstract] [Full-text]
161. The NOD mouse: a model of immune dysregulation.
     Annu Rev Immunol, 23: 447-85. [Abstract] [Full-text]
162. Effect of diabetes mellitus on female sexual function and risk factors.
     Arch Androl, 51(1): 1-6. [Abstract] [Full-text]
163. Mean platelet volume in patients with type 2 diabetes mellitus.
     Platelets, 15(8): 475-8. [Abstract] [Full-text]
164. An autosomal genomic scan for loci linked to type 2 diabetes in northern Han Chinese.
     J Mol Med, 83(3): 209-15. [Abstract] [Full-text]
165. Histomorphometric evaluation of new bone formation in diabetic rats submitted to insertion of temporary implants.
     Braz Dent J, 15(2): 87-92. [Abstract] [Full-text]
166. Sharing stories: complex intervention for diabetes education in minority ethnic groups who do not speak English.
     BMJ, 330(7492): 628. [Abstract] [Full-text]
167. Angiopoietin concentrations in diabetic retinopathy.
     Br J Ophthalmol, 89(4): 480-3. [Abstract] [Full-text]
168. Physical training reverses defect in 3-ketoacid CoA-transferase activity in skeletal muscle of diabetic rats.
     Am J Physiol Endocrinol Metab, 288(4): E748-52. [Abstract] [Full-text]
169. Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation.
     Transpl Int, 18(4): 483-6. [Abstract] [Full-text]
170. Leptin levels in obese women with and without type 2 diabetes mellitus.
     Mediators Inflamm, 13(5): 321-5. [Abstract] [Full-text]
171. Pioglitazone elicits long-term improvements in insulin sensitivity in patients with type 2 diabetes: comparisons with gliclazide-based regimens.
     Diabetologia, 48(3): 553-60. [Abstract] [Full-text]
172. A new drug carrier, Nalpha-deoxycholyl-L: -lysyl-methylester, for enhancing insulin absorption in the intestine.
     Diabetologia, 48(3): 405-11. [Abstract] [Full-text]
173. EEG abnormalities with and without relation to severe hypoglycaemia in adolescents with type 1 diabetes.
     Diabetologia, 48(3): 412-9. [Abstract] [Full-text]
174. Effect of common polymorphisms in the HNF4alpha promoter on susceptibility to type 2 diabetes in the French Caucasian population.
     Diabetologia, 48(3): 440-4. [Abstract] [Full-text]
175. Variation near the hepatocyte nuclear factor (HNF)-4alpha gene associates with type 2 diabetes in the Danish population.
     Diabetologia, 48(3): 452-8. [Abstract] [Full-text]
176. Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.
     Diabetologia, 48(3): 529-38. [Abstract] [Full-text]
177. The common T60N polymorphism of the lymphotoxin-alpha gene is associated with type 2 diabetes and other phenotypes of the metabolic syndrome.
     Diabetologia, 48(3): 445-51. [Abstract] [Full-text]
178. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy.
     Diabetologia, 48(3): 578-85. [Abstract] [Full-text]
179. Ethnicity and sex are strong determinants of diabetes in an urban Western society: implications for prevention.
     Diabetologia, 48(3): 435-9. [Abstract] [Full-text]
180. The mitochondrial rhomboid protease PSARL is a new candidate gene for type 2 diabetes.
     Diabetologia, 48(3): 459-68. [Abstract] [Full-text]
181. Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha.
     Diabetologia, 48(3): 561-8. [Abstract] [Full-text]
182. Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression.
     Diabetologia, 48(3): 569-77. [Abstract] [Full-text]
183. Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.
     Diabetologia, 48(3): 427-34. [Abstract] [Full-text]
184. Vascular dysfunction of venous bypass conduits is mediated by reactive oxygen species in diabetes: role of endothelin-1.
     J Pharmacol Exp Ther, 313(1): 70-7. [Abstract] [Full-text]
185. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes.
     Am J Physiol Endocrinol Metab, 288(4): E789-97. [Abstract] [Full-text]
186. Reduced PDX-1 expression impairs islet response to insulin resistance and worsens glucose homeostasis.
     Am J Physiol Endocrinol Metab, 288(4): E707-14. [Abstract] [Full-text]
187. Differing mechanisms of hepatic glucose overproduction in triiodothyronine-treated rats vs. Zucker diabetic fatty rats by NMR analysis of plasma glucose.
     Am J Physiol Endocrinol Metab, 288(4): E654-62. [Abstract] [Full-text]
188. Influence of the PPAR-gamma2 Pro12Ala and ACE I/D polymorphisms on insulin sensitivity and training effects in healthy offspring of type 2 diabetic subjects.
     Horm Metab Res, 37(2): 99-105. [Abstract] [Full-text]
189. Effect of 5-Campestenone (24-methylcholest-5-en-3-one) on Zucker diabetic fatty rats as a type 2 diabetes mellitus model.
     Horm Metab Res, 37(2): 79-83. [Abstract] [Full-text]
190. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content.
     Horm Metab Res, 37(2): 63-7. [Abstract] [Full-text]
191. Sustained hyperglycaemia increases muscle blood flow but does not affect sympathetic activity in resting humans.
     Eur J Appl Physiol, 93(5): 648-54. [Abstract] [Full-text]
192. Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats.
     Int J Pharm, 293(1): 271-80. [Abstract] [Full-text]
193. Oral infections and glycemic control in pregnant type 2 diabetics.
     Arch Med Res, 36(1): 42-8. [Abstract] [Full-text]
194. Renal handling of uric acid in patients with type 1 diabetes in relation to glycemic control.
     Arch Med Res, 36(1): 32-5. [Abstract] [Full-text]
195. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
     Eur J Pharmacol, 511(1): 53-64. [Abstract] [Full-text]
196. The role of impaired insulin/IGF action in primary diabetic encephalopathy.
     Brain Res, 1037(1): 12-24. [Abstract] [Full-text]
197. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.
     Eur Heart J, 26(7): 650-61. [Abstract] [Full-text]
198. Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: a phagocyte depletion study.
     Lab Invest, 85(4): 487-501. [Abstract] [Full-text]
199. Gait characteristics in people with type 2 diabetes mellitus.
     Eur J Appl Physiol, 93(5): 640-7. [Abstract] [Full-text]
200. Candidate metabolic network states in human mitochondria. Impact of diabetes, ischemia, and diet.
     J Biol Chem, 280(12): 11683-95. [Abstract] [Full-text]
201. Depressive symptoms and mortality among persons with and without diabetes.
     Am J Epidemiol, 161(7): 652-60. [Abstract] [Full-text]
202. Natural course of autoimmune thyroiditis in type 1 diabetes: association with gender, age, diabetes duration, and puberty.
     Arch Dis Child, 90(4): 411-4. [Abstract] [Full-text]
203. Twenty years of a multidisciplinary paediatric diabetes home care unit.
     Arch Dis Child, 90(4): 342-5. [Abstract] [Full-text]
204. Comparison of brain natriuretic peptide and left ventricular diastolic function determined by tissue Doppler in patients with diabetes mellitus, patients with hypertension without diabetes, and in healthy subjects.
     Am J Cardiol, 95(7): 905-8. [Abstract] [Full-text]
205. Aspirin response and failure in diabetic patients with cardiovascular disease.
     Curr Opin Pharmacol, 5(2): 190-7. [Abstract] [Full-text]
206. Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus.
     Curr Opin Pharmacol, 5(2): 184-9. [Abstract] [Full-text]
207. Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease.
     Curr Opin Pharmacol, 5(2): 149-54. [Abstract] [Full-text]
208. Cardiovascular complications in diabetes mellitus.
     Curr Opin Pharmacol, 5(2): 143-8. [Abstract] [Full-text]
209. Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients.
     J Affect Disord, 85(3): 341-50. [Abstract] [Full-text]
210. Vascular risk and low serum B12 predict white matter lesions in patients with major depression.
     J Affect Disord, 85(3): 327-32. [Abstract] [Full-text]
211. Does autoantigen administration inhibit recurrence of type 1 diabetes in transplanted islets?
     Med Hypotheses, 64(5): 986-8. [Abstract] [Full-text]
212. Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?
     Regul Pept, 128(2): 159-65. [Abstract] [Full-text]
213. Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.
     Regul Pept, 128(2): 149-57. [Abstract] [Full-text]
214. Glucagon-like peptide 1 and its derivatives in the treatment of diabetes.
     Regul Pept, 128(2): 135-48. [Abstract] [Full-text]
215. Lipid abnormalities associated with urinary albumin excretion rate in Taiwanese type 2 diabetic patients.
     Kidney Int, 67(4): 1547-53. [Abstract] [Full-text]
216. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000).
     Kidney Int, 67(4): 1489-99. [Abstract] [Full-text]
217. Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program.
     Kidney Int, 67(4): 1483-8. [Abstract] [Full-text]
218. Development of diabetic nephropathy in the Milan normotensive strain, but not in the Milan hypertensive strain: possible permissive role of hemodynamics.
     Kidney Int, 67(4): 1440-52. [Abstract] [Full-text]
219. Mechanisms of antioxidant and pro-oxidant effects of alpha-lipoic acid in the diabetic and nondiabetic kidney.
     Kidney Int, 67(4): 1371-80. [Abstract] [Full-text]
220. Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy.
     Kidney Int, 67(4): 1297-307. [Abstract] [Full-text]
221. Relapsing diabetes can result from moderately activating mutations in KCNJ11.
     Hum Mol Genet, 14(7): 925-34. [Abstract] [Full-text]
222. Optic atrophy as a sign of wolfram syndrome.
     Klin Monatsbl Augenheilkd, 222(3): 248-51. [Abstract] [Full-text]
223. Prevalence of retinopathy in Caucasian type 2 diabetic patients from the South of Brazil and relationship with clinical and metabolic factors.
     Braz J Med Biol Res, 38(2): 221-5. [Abstract] [Full-text]
224. Prevalence of type 1 diabetes among 6- to 18-year-old Kuwaiti children.
     Med Princ Pract, 14(2): 87-91. [Abstract] [Full-text]
225. Parent and adolescent versions of the diabetes-specific parental support for adolescents' autonomy scale: development and initial testing.
     J Pediatr Psychol, 30(3): 257-71. [Abstract] [Full-text]
226. Diabetes and coronary revascularization.
     JAMA, 293(12): 1501-8. [Abstract] [Full-text]
227. Placental dysfunction in Suramin-treated rats: impact of maternal diabetes and effects of antioxidative treatment.
     J Soc Gynecol Investig, 12(3): 174-84. [Abstract] [Full-text]
228. Human leukocyte antigen class I B and C loci contribute to Type 1 Diabetes (T1D) susceptibility and age at T1D onset.
     Hum Immunol, 66(3): 301-13. [Abstract] [Full-text]
229. Biphasic insulin aspart compared to biphasic human insulin reduces postprandial hyperlipidemia in patients with Type 2 diabetes.
     Exp Clin Endocrinol Diabetes, 113(3): 176-81. [Abstract] [Full-text]
230. Clinical characteristics of type 2 diabetes mellitus in overweight European caucasian adolescents.
     Exp Clin Endocrinol Diabetes, 113(3): 167-70. [Abstract] [Full-text]
231. Perinatal morbidity in women with undiagnosed gestational diabetes in northern thuringia in Germany.
     Exp Clin Endocrinol Diabetes, 113(3): 160-6. [Abstract] [Full-text]
232. Reconstituting populations through evidence-based medicine: an ethnographic account of recommending procedures for diagnosing type 2 diabetes in clinical practice guidelines.
     Health (London), 9(2): 241-66. [Abstract] [Full-text]
233. Oxysterols increase in diabetic rats.
     Free Radic Res, 39(3): 299-304. [Abstract] [Full-text]
234. Beliefs about health and diabetes in men of different ethnic origin.
     J Adv Nurs, 50(1): 47-59. [Abstract] [Full-text]
235. Effects of a supranutritional dose of selenate compared with selenite on insulin sensitivity in type II diabetic dbdb mice.
     J Anim Physiol Anim Nutr (Berl), 89(3): 94-104. [Abstract] [Full-text]
236. Self-monitoring of blood glucose in children and teens with diabetes.
     Pediatr Diabetes, 6(1): 50-62. [Abstract] [Full-text]
237. A randomized trial of regular standardized telephone contact by a diabetes nurse educator in adolescents with poor diabetes control.
     Pediatr Diabetes, 6(1): 32-40. [Abstract] [Full-text]
238. Insulin pump use in young adolescents with type 1 diabetes: a descriptive study.
     Pediatr Diabetes, 6(1): 22-31. [Abstract] [Full-text]
239. Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective.
     Pediatr Diabetes, 6(1): 17-21. [Abstract] [Full-text]
240. Insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity.
     Pediatr Diabetes, 6(1): 5-12. [Abstract] [Full-text]
241. Dysfunction of the cyclo-oxygenase pathway in the foetoplacental circulation in Type 1 diabetes mellitus.
     Diabet Med, 22(4): 503-6. [Abstract] [Full-text]
242. Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetes.
     Diabet Med, 22(4): 497-502. [Abstract] [Full-text]
243. Criteria for previously undiagnosed diabetes and risk of mortality: 15-year follow-up of the Edinburgh Artery Study cohort.
     Diabet Med, 22(4): 490-6. [Abstract] [Full-text]
244. Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes?
     Diabet Med, 22(4): 483-9. [Abstract] [Full-text]
245. Prevalence and risk factors for stroke in Type 2 diabetic patients in Taiwan: a cross-sectional survey of a national sample by telephone interview.
     Diabet Med, 22(4): 477-82. [Abstract] [Full-text]
246. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
     Diabet Med, 22(4): 470-6. [Abstract] [Full-text]
247. Clinical characteristics of diabetic ketoacidosis in Korea over the past two decades.
     Diabet Med, 22(4): 466-9. [Abstract] [Full-text]
248. Transcutaneous oxygen tension monitoring after successful revascularization in diabetic patients with ischaemic foot ulcers.
     Diabet Med, 22(4): 460-5. [Abstract] [Full-text]
249. Increased renal glucose metabolism in Type 1 diabetes mellitus.
     Diabet Med, 22(4): 453-9. [Abstract] [Full-text]
250. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
     Diabet Med, 22(4): 448-52. [Abstract] [Full-text]
251. Birthweight and other pregnancy outcomes in a cohort of women with pre-gestational insulin-treated diabetes mellitus, Scotland, 1979-95.
     Diabet Med, 22(4): 440-7. [Abstract] [Full-text]
252. Effect of maternal diabetes on phosphorylation of insulin-like growth factor binding protein-1 in cord serum.
     Diabet Med, 22(4): 434-9. [Abstract] [Full-text]
253. Is the relationship between adherence behaviours and glycaemic control bi-directional at adolescence? A longitudinal cohort study.
     Diabet Med, 22(4): 427-33. [Abstract] [Full-text]
254. School attendance in children with Type 1 diabetes.
     Diabet Med, 22(4): 421-6. [Abstract] [Full-text]
255. Role of habit in adherence to medical treatment.
     Diabet Med, 22(4): 415-20. [Abstract] [Full-text]
256. Teaching and motivating patients to control their risk factors retards progression of cardiovascular as well as microvascular sequelae of Type 2 diabetes mellitus- a randomized prospective 8 years follow-up study.
     Diabet Med, 22(4): 410-4. [Abstract] [Full-text]
257. Preserved insulin response to tolbutamide in hepatocyte nuclear factor-1alpha mutation carriers.
     Diabet Med, 22(4): 406-9. [Abstract] [Full-text]
258. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
     Diabet Med, 22(4): 399-405. [Abstract] [Full-text]
259. Electrical spinal cord stimulation in the long-term treatment of chronic painful diabetic neuropathy.
     Diabet Med, 22(4): 393-8. [Abstract] [Full-text]
260. Tumour necrosis factor receptors (TNFRs) in Type 2 diabetes. Analysis of soluble plasma fractions and genetic variations of TNFR2 gene in a case-control study.
     Diabet Med, 22(4): 387-92. [Abstract] [Full-text]
261. Optimization of basal insulin delivery in Type 1 diabetes: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine.
     Diabet Med, 22(4): 382-6. [Abstract] [Full-text]
262. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes.
     Diabet Med, 22(4): 374-81. [Abstract] [Full-text]
263. Animal models of diabetes mellitus.
     Diabet Med, 22(4): 359-70. [Abstract] [Full-text]
264. Small molecule glucokinase activators as novel anti-diabetic agents.
     Biochem Soc Trans, 33: 371-4. [Abstract] [Full-text]
265. PDH kinase inhibitors: a novel therapy for Type II diabetes?
     Biochem Soc Trans, 33: 367-70. [Abstract] [Full-text]
266. Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes.
     Biochem Soc Trans, 33: 354-7. [Abstract] [Full-text]
267. Therapeutic challenges of kinase and phosphatase inhibition and use in anti-diabetic strategy.
     Biochem Soc Trans, 33: 343-5. [Abstract] [Full-text]
268. Introduction to the Kinases in Diabetes Biochemical Society Focused Meeting: are protein kinases good targets for antidiabetic drugs?
     Biochem Soc Trans, 33: 339-42. [Abstract] [Full-text]
269. Symptoms of unstable angina in patients with and without diabetes.
     Res Nurs Health, 28(2): 136-43. [Abstract] [Full-text]
270. Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes.
     J Am Soc Nephrol, 16(4): 1069-75. [Abstract] [Full-text]
271. T-786C polymorphism of the endothelial nitric oxide synthase gene is associated with albuminuria in the diabetes heart study.
     J Am Soc Nephrol, 16(4): 1085-90. [Abstract] [Full-text]
272. An alternative formula to the Cockcroft-Gault and the modification of diet in renal diseases formulas in predicting GFR in individuals with type 1 diabetes.
     J Am Soc Nephrol, 16(4): 1051-60. [Abstract] [Full-text]
273. Chronic angiotensin II receptor blockade reduces (intra)renal vascular resistance in patients with type 2 diabetes.
     J Am Soc Nephrol, 16(4): 1135-40. [Abstract] [Full-text]
274. Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study.
     Clin Chem, 51(4): 753-8. [Abstract] [Full-text]
275. Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients.
     Eur J Hum Genet, 13(4): 422-7. [Abstract] [Full-text]
276. One hour versus two hours postprandial glucose measurement in gestational diabetes: a prospective study.
     J Perinatol, 25(4): 241-4. [Abstract] [Full-text]
277. Heterogeneity in distribution of amyloid-positive islets in type-2 diabetic patients.
     Virchows Arch, 446(3): 232-8. [Abstract] [Full-text]
278. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
     Can J Physiol Pharmacol, 83(2): 183-90. [Abstract] [Full-text]
279. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
     Invest Ophthalmol Vis Sci, 46(4): 1440-4. [Abstract] [Full-text]
280. The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice.
     Immunol Rev, 204: 250-63. [Abstract] [Full-text]
281. The stages of type 1A diabetes: 2005.
     Immunol Rev, 204: 232-49. [Abstract] [Full-text]
282. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists.
     Hypertension, 45(4): 526-9. [Abstract] [Full-text]
283. Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus.
     Hypertension, 45(4): 659-65. [Abstract] [Full-text]
284. Neural network modeling and control of type 1 diabetes mellitus.
     Bioprocess Biosyst Eng, 27(2): 75-9. [Abstract] [Full-text]
285. Spectral and directional reflectance of the fovea in diabetes mellitus: photoreceptor integrity, macular pigment and lens.
     Vision Res, 45(13): 1745-53. [Abstract] [Full-text]
286. Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats.
     Life Sci, 76(23): 2655-68. [Abstract] [Full-text]
287. Sensitivity and specificity of electrodiagnostic criteria for CIDP using ROC curves: comparison to patients with diabetic and MGUS associated neuropathies.
     J Neurol Sci, 231(1): 19-28. [Abstract] [Full-text]
288. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
     Eur J Pharmacol, 511(2): 191-8. [Abstract] [Full-text]
289. Unraveling the pathogenesis of type 1 diabetes with proteomics: present and future directions.
     Mol Cell Proteomics, 4(4): 441-57. [Abstract] [Full-text]
290. Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes.
     J Biol Chem, 280(13): 12310-5. [Abstract] [Full-text]
291. CBLB variants in type 1 diabetes and their genetic interaction with CTLA4.
     J Leukoc Biol, 77(4): 579-85. [Abstract] [Full-text]
292. Ankle fractures in patients with diabetes mellitus.
     J Bone Joint Surg Br, 87(4): 489-95. [Abstract] [Full-text]
293. Choline acetyltransferase and inducible nitric oxide synthase are increased in myenteric plexus of diabetic guinea pig.
     Auton Neurosci, 118(1): 12-24. [Abstract] [Full-text]
294. Gene transfer of vasoactive intestinal polypeptide into the penis improves erectile response in the diabetic rat.
     BJU Int, 95(6): 890-4. [Abstract] [Full-text]
295. Accumulation of long-chain acylcarnitine and 3-hydroxy acylcarnitine molecular species in diabetic myocardium: identification of alterations in mitochondrial fatty acid processing in diabetic myocardium by shotgun lipidomics.
     Biochemistry, 44(13): 5234-45. [Abstract] [Full-text]
296. Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama.
     Biochemistry, 44(13): 5000-16. [Abstract] [Full-text]
297. High-sensitivity C-reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients.
     Metabolism, 54(4): 552-8. [Abstract]